EU fines Teva, Cephalon 60.5 mln euros for delaying cheaper drug

Click For Larger Image & Read More
EU fines Teva, Cephalon 60.5 mln euros for...
 © In-Cyprus 2021
The European Commission on Thursday (November 26) fined pharmaceutical company Teva and its now subsidiary Cephalon 60.5 million euros for agreeing to delay a cheaper generic version of Cephalon’s sleep disorder medicine.

Cephalon induced Teva not to enter the market with a cheaper generic version in exchange for a package of commercial side-deals beneficial to Teva and some cash payments, European Commission Executive Vice-President Margrethe Vestager told a news conference.

The agreement with Teva to delay the market entry of the generic drug Modafinil after Cephalon’s main patents had...


Read all latest: Cyprus Coronavirus News Updates - Live

This article was automatically added to our system 26-11-2020

EU fines Teva, Cephalon 60.5 mln euros for delaying cheaper drug


The contents of this article including any associated images are © In-Cyprus 2021
Views & opinions expressed in this article are those of the author and/or In-Cyprus .

Advertise Here

  Trending Cyprus News

Advertise Here

Article Tags: fines, cephalon, euros, delaying, cheaper,